EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and Validation of Spectrophotometric Method for Determination of Levofloxacin in Rat Plasma

Tahir Suleymanov, Emilya Balayeva iD, Elnur Gasimov iD, Aytac Badalova iD, Kubra Aliyeva

Molecules · 05.03.2026 · 31 (5) · 869

DOI: 10.3390/molecules31050869 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 05.03.2026. Verfasst von Tahir Suleymanov und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Azerbaijan Medical University, Baku 1022, Azerbaijan. Hauptthemen laut MEDLINE: Levofloxacin, Anti-Bacterial Agents. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A simple, rapid, and cost-effective UV–Vis spectrophotometric method was developed and validated for the determination of levofloxacin in rat plasma to support the evaluation of a novel antimicrobial mesh implant containing levofloxacin, chitosan, gelatin, tinctura propolis, citric, acid and glycerin. Plasma samples were treated with 0.1 M HCl, and absorbance was measured at 290 nm. The method was validated according to FDA and ICH guidelines, including assessments of linearity, sensitivity, accuracy, precision, and specificity. The calibration curve was linear over the concentration range of 2.5–12.5 μg/mL (R2 = 0.999, p < 0.001). The limit of detection and limit of quantification were 0.21 μg/mL and 0.62 μg/mL, respectively. Intra- and inter-day precision showed low relative standard deviation values (0.2% and 0.25%), while recovery ranged from 94.8% to 96.4%, confirming acceptable accuracy. No significant interference from plasma matrix components was observed. Compared with chromatographic techniques, the proposed method provides an accessible alternative for routine bioanalysis and therapeutic monitoring. The validated assay is suitable for assessing prolonged levofloxacin release from implantable drug delivery systems in preclinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevofloxacinAnti-Bacterial AgentsAnimalsRatsSpectrophotometryReproducibility of ResultsSpectrophotometry, UltravioletLimit of Detection

Stichwörter der Autor:innen

accuracybloodhernia meshlevofloxacin prolongedlinearityultraviolet–visible spectrophotometryvalidation

Substanzen

LevofloxacinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Azerbaijan Medical University, Baku 1022, Azerbaijan.
  • Department of General Surgery, Azerbaijan Medical University, Baku 1022, Azerbaijan.
  • Department of Pathophysiology, Azerbaijan Medical University, Baku 1022, Azerbaijan.
  • Department of Pharmaceutical Technology and Management, Azerbaijan Medical University, Baku 1022, Azerbaijan.

ORCID-Profile: Emilya Balayeva, Elnur Gasimov, Aytac Badalova

Zitieren

APA

Suleymanov, T., Balayeva, E., Gasimov, E., Badalova, A., & Aliyeva, K. (2026). Development and Validation of Spectrophotometric Method for Determination of Levofloxacin in Rat Plasma. Molecules, 31(5), 869. https://doi.org/10.3390/molecules31050869

Vancouver

Suleymanov T, Balayeva E, Gasimov E, Badalova A, Aliyeva K. Development and Validation of Spectrophotometric Method for Determination of Levofloxacin in Rat Plasma. Molecules. 2026;31(5):869. doi:10.3390/molecules31050869

BibTeX
@article{Suleymanov2026,
  author = {Suleymanov, Tahir and Balayeva, Emilya and Gasimov, Elnur and Badalova, Aytac and Aliyeva, Kubra},
  title = {Development and Validation of Spectrophotometric Method for Determination of Levofloxacin in Rat Plasma},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {5},
  pages = {869},
  doi = {10.3390/molecules31050869}
}
Kostenlos starten →